PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Allen Institute for Immunology partners with Lilly to better understand autoimmune disease

The Institute will use cutting-edge molecular profiling techniques and advanced bioinformatics tools to enable precision medicine in clinical trials in eczema and rheumatoid arthritis

Allen Institute for Immunology partners with Lilly to better understand autoimmune disease
2023-07-18
(Press-News.org) SEATTLE — July 18, 2023 — In a significant milestone for the Allen Institute for Immunology, a division of the Allen Institute, researchers and staff will collaborate with private industry researchers to aid in the detailed molecular understanding of disease, in service of developing new treatments and therapies to improve human health.

Specifically, Allen Institute scientists will work with researchers from Eli Lilly and Company (Lilly) to investigate and profile disease state diversity and biomarkers for drug response involving atopic dermatitis (eczema) and rheumatoid arthritis using Allen Institute-developed unique molecular tools and comprehensive bioinformatic analysis techniques. 

“Since the creation of the Institute in 2018, we have developed cutting-edge technologies that allow an unprecedented understanding of the human immune system in both health and disease,” said Peter Skene, Ph.D., Director of High Resolution Translational Immunology at the Allen Institute for Immunology. “By partnering with Lilly, we will further our translational mission of impact for patients.”

This first industry partnership represents the culmination of the last four years of work and research by the Allen Institute for Immunology. The important collaboration points to the future trajectory of the Institute’s ongoing efforts to better understand the contours of the human immune system in both health and disease: industry collaborations aimed at translating foundational insight and cutting-edge analysis tools into new treatments and therapies for disease.

It underscores the importance of foundational, basic science in advancing medicine for society and highlights the potential of the Institute’s research pipelines, tools, and resources for others in the field. 


About the Allen Institute for Immunology
The Allen Institute for Immunology is a division of the Allen Institute, an independent, 501(c)(3) nonprofit medical research organization, and is dedicated to understanding the dynamic balancing act of the human immune system in health and disease. The Allen Institute for Immunology will advance our fundamental understanding of the human immune system and will identify new therapeutic avenues for disease by employing a multi-disciplinary team approach in collaboration with leading research organizations, generating novel insights about cellular and molecular drivers of immune health and immune-related diseases. The Allen Institute for Immunology was launched in 2018 with a contribution from founder and philanthropist, the late Paul G. Allen. The data and tools generated by the Allen Institute for Immunology are publicly available online. For more information visit https://alleninstitute.org/division/immunology/.

# # #

Media Contact
Peter Kim, Sr. Manager, Media Relations
206.605.9884 | peter.kim@alleninstitute.org 
 

END


[Attachments] See images for this press release:
Allen Institute for Immunology partners with Lilly to better understand autoimmune disease Allen Institute for Immunology partners with Lilly to better understand autoimmune disease 2 Allen Institute for Immunology partners with Lilly to better understand autoimmune disease 3

ELSE PRESS RELEASES FROM THIS DATE:

Using AI to speed up vaccine development against Disease X

Using AI to speed up vaccine development against Disease X
2023-07-18
CEPI, the Coalition for Epidemic Preparedness Innovations, and the Houston Methodist Research Institute (HMRI), have today announced a partnership to combine cutting-edge artificial intelligence (AI) technology with established laboratory techniques to speed up development of future vaccines against novel viral threats (also known as Disease X). HMRI will lead a consortium including experts from Argonne National Laboratory (University of Chicago), J Craig Venter Research Institute, La Jolla Institute, The University of Texas Medical Branch, and The University of Texas, ...

Japanese beetles could spread throughout Washington state in 20 years

2023-07-18
PULLMAN, Wash. – Without intervention, the colorful but devastating Japanese beetle could make its way across the evergreen state within two decades, according to a study of their potential dispersion. The iridescent, green-and-copper beetles damage plants by “skeletonizing” their leaves, chewing up all the soft green parts between the veins. They eat over 300 plants and pose a serious threat to Washington agriculture as some of their favorite crops include grapes, hops and cherries.  Once established, Japanese beetles are tough to eradicate, but it may be possible to keep them under control, said David Crowder, a Washington State University entomologist. “These ...

Will artificial intelligence (AI) end civilization? Lero researchers seek public's views on AI and software

2023-07-18
Will artificial intelligence (AI) end civilisation? Researchers at Lero, the Science Foundation Ireland Research Centre for Software and University College Cork, are seeking help determining what the public believes and knows about AI and software more generally. Psychologist Dr Sarah Robinson, a senior postdoctoral researcher with Lero, is asking members of the public to take part in a ten-minute anonymised online survey to establish what peoples’ hopes and fears are for AI and software in general. “As the experts debate, little attention is given to what the public thinks – and the debate is raging. Some ...

NIH grant backs Rice U. lab’s sickle cell disease research

NIH grant backs Rice U. lab’s sickle cell disease research
2023-07-18
HOUSTON – (July 18, 2023) – Rice University bioengineer Gang Bao and his team have won a 4-year, $2.6 million grant from the National Institutes of Health to address critical questions surrounding the safety and efficacy of using gene editing to treat sickle cell disease. Because it is caused by a mutation in a single gene, sickle cell disease is a prime candidate for gene editing treatments using tools such as CRISPR-Cas9. “Sickle cell disease affects over five million people worldwide, and ...

EMBARGOED: Women less likely to be routed to comprehensive stroke centers for large vessel acute ischemic stroke, according to UTHealth Houston research

2023-07-18
Despite having worse stroke symptoms and living within comparable distances to comprehensive stroke centers, women with large vessel occlusion acute ischemic stroke are less likely to be routed to the centers compared to men, according to a new study from UTHealth Houston. Led by corresponding author Sunil Sheth, MD, associate professor of neurology and director of the vascular neurology program with McGovern Medical School at UTHealth Houston, and senior author Youngran Kim, PhD, assistant professor of management, policy, and community health with UTHealth Houston School of Public Health, the study was published today in the Journal of the American ...

IOP Publishing’s latest Environmental Research series journals now open for submissions

IOP Publishing’s latest Environmental Research series journals now open for submissions
2023-07-18
IOP Publishing’s (IOPP) new environmental research journals are now open for submissions. Announced earlier this year, the two new open access (OA) journals: Environmental Research: Energy and Environmental Research: Food Systems are the latest additions to IOPP’s expanding Environmental Research Series which now includes eight open access titles.   IOPP’s Environmental Research series builds on the established reputation of the journal Environmental Research Letters (ERL) and shares the same outstanding levels of author service, inclusive editorial policies, strict quality assurance and has open science principles at its core.   IOP ...

This sugar kills honeybees—it could also help fight cancer

This sugar kills honeybees—it could also help fight cancer
2023-07-18
LA JOLLA, CALIF. – July 18, 2023 –Research from Sanford Burnham Prebys and the Osaka International Cancer Institute has shed new light on the anti-cancer properties of mannose, a sugar that is crucial to many physiological processes in humans and is also known to inhibit the growth of cancer cells. The findings, published in the journal eLife, suggest that mannose could be a helpful secondary treatment for cancer. “This sugar could give cancer an extra punch alongside other treatments,” says study co-author Hudson Freeze, Ph.D., director of the Human Genetics ...

Smiles all round: clinical trial shows that a toothpaste containing synthetic tooth minerals can prevent cavities as effectively as fluoride

2023-07-18
Brushing twice a day keeps the dentist away – but can we improve on the toothpaste we use to maintain clean teeth, preventing medical issues that spiral from poor dental health? Most toothpastes use fluoride, a powerful tool for oral hygiene. However, fluoride can pose health problems in some cases, especially for children who consume too much fluoride by swallowing most of their toothpaste: children normally use only a tiny dose of toothpaste to avoid these problems, but that reduces toothbrushing efficacy. In the search for alternatives, a team of international scientists and Polish clinicians have identified a hydroxyapatite toothpaste that works just as well as fluoride toothpaste ...

A new way to browse interlinked biodiversity data: The Biodiversity Knowledge Hub is now online!

A new way to browse interlinked biodiversity data: The Biodiversity Knowledge Hub is now online!
2023-07-18
The Horizon 2020 BiCIKL Project is proud to announce that the Biodiversity Knowledge Hub (BKH) is now online. BKH is a one-stop portal that allows users to access FAIR and interlinked biodiversity data and services in a few clicks. BKH was designed to support a new emerging community of users over time and across the entire biodiversity research cycle providing its services to anybody, anywhere and anytime. “The Knowledge Hub is the main product from our BiCIKL consortium, and we are delighted with the result! BKH can easily be seen as the beginning of the major shift in the way we search interlinked biodiversity information,” says Prof. Lyubomir ...

The double face of RNase as a treatment for systemic autoimmune diseases

The double face of RNase as a treatment for systemic autoimmune diseases
2023-07-18
Osaka, Japan – Systemic autoimmune diseases are characterized by inflammation of multiple organs and can have devastating consequences for patients. There is a dire need for treatments against these diseases. RNase treatments seem promising in some clinical trials but not all. Researchers from Japan have uncovered the reasons for this variability. In a study recently published in the Journal of Clinical Investigation Insight (JCI Insight), researchers from Osaka University have provided new insights into the opposite effects of RNase ...

LAST 30 PRESS RELEASES:

Deep-learning framework advances tissue analysis in spatial transcriptomics

From dormant to danger: How VZV reactivation is driving CNS infections

DNA barcodes narrow down possible sources of introductions of an invasive banana skipper butterfly pest

Transforming clinical care for children with rare genetic diseases

Polar bear cubs emerging from their dens for the first time: New study captures rare footage

Turning waste organic compound into useful pharmaceuticals and energy using a technique inspired by photosynthesis

Violence alters human genes for generations, researchers discover

Scientists discover key protein in resilience to stress

Nasal spray shows preclinical promise for treating traumatic brain injury

Cambridge initiative to address risks of future engineered pandemics

Unmasking inequalities in AI: new research reveals how artificial intelligence might reinforce inequality

Taking sports science in her stride: How Dr. Nerea Casal García aims to maximize performance on the track

Pioneering work generates feline embryonic stem cells in boon for cats

Decoding the link between colorectal cancer risk and steatotic liver disease

Controlling conformational changes in protein aromatic side chains

Experimental and numerical analysis of the potential drop method for defects caused by dynamic loads

Chinese researchers make breakthrough in artificial chiral structural-color microdomes

Intermittent fasting inhibits platelet activation to reduce thrombosis risk

A clear game-changer: Curtin’s water-repellent glass breaks new ground

Are our refrigerants safe? The lingering questions about the chemicals keeping us cool

How nitrogen reshapes root system architecture in plants?

‘Fluorescent phoenix’ discovered with persistence rivaling Marie Curie’s

A rapid and reproducible method for generating germ-free Drosophila melanogaster

Aging and the brain’s sugar-coated shield

Better poverty mapping: New machine-learning approach targets aid more effectively

An emissions tale of two cities: Salt Lake City vs. Los Angeles

WVU nursing faculty aim to enhance rural home care for chronically ill through NIH award

New screening tool for stroke survivors with visual perception problems

Influencer marketing can help tourism industry mitigate waste, pollution

Tufts named a top producer of U.S. Fulbright students

[Press-News.org] Allen Institute for Immunology partners with Lilly to better understand autoimmune disease
The Institute will use cutting-edge molecular profiling techniques and advanced bioinformatics tools to enable precision medicine in clinical trials in eczema and rheumatoid arthritis